SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2020-06-12 17:33
Tx date 2020-06-10
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$51,034
+3,800 vol
$13.43 each
18,420
Filed 2020-06-02 19:51
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$131,100
+10,000 vol
$13.11 each
35,000
Filed 2020-06-01 16:59
Tx date 2020-05-31
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$72,004
+4,960 vol
$14.52 each
42,116
Filed 2020-04-01 18:06
Tx date 2020-04-01
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
136,111
Filed 2020-01-14 15:11
Tx date 2020-01-13
$XENE
Xenon Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
25,000
Filed 2020-01-14 15:07
Tx date 2020-01-13
$XENE
Xenon Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-20 17:00
Tx date 2019-08-15
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-288,889 vol
111,111
Filed 2019-08-20 16:59
Tx date 2019-08-15
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
37 - Stock split or consolidation

-96,604 vol
37,156
Filed 2019-08-20 16:58
Tx date 2019-08-15
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-38,012 vol
14,620
Filed 2019-05-31 14:28
Tx date 2019-05-31
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$45,000
+30,858 vol
$1.46 each
133,760
Filed 2019-04-22 10:15
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash

-1,657,757 vol
0
Filed 2019-04-22 10:14
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$-20,351,350
-814,054 vol
$25.00 each
0
Filed 2019-04-10 12:20
Tx date 2019-04-09
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership

+814,054 vol
814,054
Filed 2019-04-10 12:20
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-10 12:19
Tx date 2019-04-09
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

-814,054 vol
0
Filed 2019-02-21
Tx date 2019-02-20
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
400,000
Filed 2019-02-21
Tx date 2019-02-18
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+463,300 vol
1,657,757
Filed 2018-12-18
Tx date 2017-09-27
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-12-18
Tx date 2018-12-18
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$50,000
+52,632 vol
$0.95 each
52,632
Filed 2018-05-31
Tx date 2018-05-31
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$45,000
+78,603 vol
$0.57 each
102,902
Filed 2018-04-20
Tx date 2018-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
1,194,457
Filed 2018-03-16
Tx date 2018-03-15
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$11,250
+24,299 vol
$0.463 each
24,299
Filed 2018-03-16
Tx date 2017-09-27
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-02
Tx date 2018-02-27
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+305,000 vol
1,094,457
Filed 2018-02-23
Tx date 2018-02-20
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
300,000
Filed 2017-11-09
Tx date 2017-09-27
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-11-09
Tx date 2017-11-07
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
150,000
Filed 2017-08-22
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
789,457
Filed 2017-08-22
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
814,054